Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

U.S. stocks mixed, as strong jobs data support 2015 rate hike

Published 06/05/2015, 04:19 PM
Updated 06/05/2015, 04:39 PM
The Dow and S&P 500 fell mildly on Friday, while the NASDAQ inched higher

Investing.com -- U.S. stocks were mixed on Friday, as optimistic U.S. jobs data sent strong indications that the Federal Reserve could lift interest rates at some point this year.

The U.S. Bureau of Labor Statistics said on Friday morning that non-farm payrolls for the month of May soared by 280,000, far exceeding analysts' low end of forecasts for a 220,000 gain. Private payrolls increased by 262,000 in May, as professional business services added 63,000 positions on the month. The labor market also added 17,000 construction position, following a significant gain of 35,000 a month earlier.

Stocks on the Dow Jones Industrial Average and the S&P 500 Composite index fell mildly during a choppy session, while the NASDAQ Composite index inched up bolstered by gains in the energy industry. Energy stock gained more than 0.75% on the session after OPEC decided to lower its production ceiling below 30 million barrels per day at a meeting in Vienna.

The Dow lost 56.12 or 0.31%, to close at 17,849.46, finishing down for the week. The NASDAQ, meanwhile, gained 9.33 or 0.18% to 5,068.46.

The S&P 500 lost 3.01 or 0.14% to 2,092.83, as six of 10 sectors closed in the red. Stocks in the Telecommunications and Utilities sectors lagged, each closing down by more than 1.25% while stocks in the Energy and Financials sectors led.

The top performer on the Dow was JPMorgan Chase & Co (NYSE:JPM), which gained 1.09 or 1.64% to 67.42. The worst performer was Verizon Communications Inc (NYSE:VZ), which fell 0.87 or 1.81% to 47.23.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The biggest gainer on the NASDAQ was Regeneron Pharmaceuticals Inc (NASDAQ:REGN), which rose 20.42 or 3.94% to 539.04 after the U.S. Food and Drug Administration said its experimental drug aimed at lowering LDL cholesterol was generally well-accepted. The worst performer was VimpelCom (NASDAQ:VIP), which fell 0.39 or 6.53% to 5.58. VIP finished just ahead of Vodafone (NASDAQ:VOD) Group PLC (LONDON:VOD), which lost 0.66 or 1.75% to 37.05.

Regeneron was also the top performer on the S&P 500, ahead of Zions Bancorporation (NASDAQ:ZION), which gained 1.62 or 3.44% to 31.85 days after announcing a comprehensive corporate restructuring plan earlier this week. The worst performer was Altria Group (NYSE:MO), which dropped 1.67 or 3.35 to 48.21.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.